Anti-Cancer Agents in Medicinal Chemistry
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.6 | Q3 | 41.4% | 0.584 | Q3 | 66.6% |
| 2024 | 3.0 | Q2 | 56.1% | 0.562 | Q3 | 66.2% |
| 2023 | 2.6 | Q3 | 42.9% | 0.503 | Q3 | 65.1% |
| 2022 | 2.8 | Q3 | 39.8% | 0.428 | Q3 | 61.3% |
| 2021 | 2.5 | Q4 | 36.6% | 0.403 | Q3 | 60.5% |
| 2020 | — | — | 0.508 | Q3 | 66.7% | |
| 2019 | — | — | 0.543 | Q3 | 69.7% | |
| 2018 | — | — | 0.528 | Q3 | 66.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1875-5992
ISSN
1871-5206
region
Middle East
coverage
2006-2026